Early versus delayed cardioversion: why should we wait?
1Heart Center, Turku University Hospital, University of Turku, Turku, Finland.
Insights
Timing cardioversion (CV) for atrial fibrillation (AF) impacts success. Early CV (12-48 hours) improves outcomes and reduces recurrence, but effective anticoagulation is crucial to prevent complications.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Cardioversion (CV) is key for atrial fibrillation (AF) rhythm control.
- The timing of CV significantly influences treatment efficacy and safety.
Purpose of the Study:
- To review how the timing of CV affects the success and safety of rhythm control for AF.
- To identify optimal timing for CV based on current evidence.
Main Methods:
- Review of observational studies on CV timing in AF.
- Analysis of data regarding CV success rates, recurrence, and complications based on timing.
Main Results:
- CV success is higher for acute (<48 hours) AF compared to persistent AF.
- Early CV timing appears to reduce AF recurrences.
- Delayed CV increases thromboembolic risk despite anticoagulation.
- Arrhythmic complications post-CV are rare regardless of timing.
Conclusions:
- Optimal CV timing is likely 12-48 hours after symptom onset.
- Evaluate treatment failure probability and antiarrhythmic options before CV.
- Effective anticoagulation is critical, especially during the first week post-CV.
Abstract:
Introduction: Cardioversion (CV) is the essential component of rhythm control strategy for atrial fibrillation (AF). This review will focus on how the timing of CV affects the efficacy and safety of rhythm control strategy.Areas covered: There are no randomized studies assessing the effect of timing on CV outcome. Based on observational studies, the success of CV of acute (<48 hours) AF is consistently better than the later CV of persistent AF. Early AF recurrences are common, but early timing of CV seems to reduce recurrences. Risk of thromboembolic complications increases with the delay of CV in spite of the use of therapeutic anticoagulation. Clinically significant arrhythmic complications are rare after CV irrespective of procedure timing.Expert opinion: Based on observational studies the optimal timing of CV seems to be at 12-48 h after the onset of arrhythmic symptoms. Before proceeding to CV, the probability of early treatment failure and antiarrhythmic treatment options should be carefully evaluated to avoid the risks of repeated futile CVs. Effective anticoagulation is crucial to prevent thromboembolic complications. The first week after CV is the most vulnerable period in this respect.
Related Concept Videos
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
01:25Dysrhythmias VI: Management of Dysrhythmias
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
01:30Dysrhythmias V: Evaluating Dysrhythmias
01:26Cardiac Catheterization IV: Nursing Management
01:25Correlation between ECG and Cardiac Cycle
A cardiac action potential originates in the SA node and spreads throughout the atria and the AV node in approximately 0.03 seconds. This results in the P wave in an ECG and triggers atrial contraction. The action potential is then briefly slowed at the AV node, allowing the atria to contract and fill the ventricles with blood before...